Approval · Notice of Compliance 3966 · 1997
RELAFEN: Notice of Compliance 3966
Issued May 21, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3966
- Date
- May 21, 1997
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form and strength
- Therapeutic class
- Nonsteroidal anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RELAFEN | 02231352 | — |
Medicinal ingredients
- NABUMETONE 1,000 MG per TAB